XOMA (XOMA) Competitors

Dynavax Technologies (NASDAQ:DVAX) and XOMA (NASDAQ:XOMA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation, community ranking and dividends.

Is DVAX or XOMA more profitable?

Dynavax Technologies has a net margin of 9.85% compared to XOMA's net margin of -151.34%. Dynavax Technologies' return on equity of 4.22% beat XOMA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynavax Technologies	9.85%	4.22%	2.67%
XOMA	-151.34%	-24.95%	-9.64%

Does the media refer more to DVAX or XOMA?

In the previous week, XOMA had 5 more articles in the media than Dynavax Technologies. MarketBeat recorded 12 mentions for XOMA and 7 mentions for Dynavax Technologies. Dynavax Technologies' average media sentiment score of 1.31 beat XOMA's score of 1.02 indicating that Dynavax Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Dynavax Technologies	6 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
XOMA	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend DVAX or XOMA?

Dynavax Technologies presently has a consensus target price of $24.00, suggesting a potential upside of 130.33%. XOMA has a consensus target price of $69.50, suggesting a potential upside of 161.28%. Given XOMA's stronger consensus rating and higher probable upside, analysts clearly believe XOMA is more favorable than Dynavax Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynavax Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
XOMA	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk and volatility, DVAX or XOMA?

Dynavax Technologies has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, XOMA has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500.

Does the MarketBeat Community believe in DVAX or XOMA?

Dynavax Technologies received 35 more outperform votes than XOMA when rated by MarketBeat users. Likewise, 65.79% of users gave Dynavax Technologies an outperform vote while only 65.58% of users gave XOMA an outperform vote.

Company	Underperform	Outperform
Dynavax Technologies	Outperform Votes 477 65.79%	Underperform Votes 248 34.21%
XOMA	Outperform Votes 442 65.58%	Underperform Votes 232 34.42%

Which has stronger earnings & valuation, DVAX or XOMA?

Dynavax Technologies has higher revenue and earnings than XOMA. XOMA is trading at a lower price-to-earnings ratio than Dynavax Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynavax Technologies	$294.62M	4.25	-$6.39M	-$0.52	-20.04
XOMA	$13.05M	24.40	-$40.83M	-$1.15	-23.13

Do institutionals & insiders have more ownership in DVAX or XOMA?

97.0% of Dynavax Technologies shares are owned by institutional investors. Comparatively, 95.9% of XOMA shares are owned by institutional investors. 3.0% of Dynavax Technologies shares are owned by company insiders. Comparatively, 7.2% of XOMA shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Dynavax Technologies beats XOMA on 13 of the 18 factors compared between the two stocks.